Latest Share Chat

REMOVE ADS

Provexis Regulatory News (PXS)

Provexis Information

Share Price Information for Provexis (PXS)

Share Price is delayed by 15 minutes

Get Live Data

1.10 -0.05 (-4.55%)

Bid:

1.00

Ask:

1.10

Spread: 0.10 (10.00%)

Market Cap: £25.80m

Last checked at -

Intraday Provexis Share Chart

REMOVE ADS

Change of Adviser

20 Oct 2009 07:00

RNS Number : 0344B

Provexis PLC

20 October 2009

Provexis plc

("Provexis" or "the Company")

Change of Adviser

Provexis, the life-science business that discovers, develops and licenses scientifically-proven functional food, medical food and dietary supplement technologies, announces the appointment of Evolution Securities Limited as its Nominated Adviser and Broker with immediate effect.

20 October 2009

For more information please contact:

Provexis plc	01753 752 290
Stephen Moon, Chief Executive
Ian Ford, Finance Director

Evolution Securities Limited (NOMAD)	0207071 4300
Sam Plumptre Bobbie Hilliam

This information is provided by RNS

The company news service from the London Stock Exchange

END

APPEALENFSNNFFE

Date		Source	Headline
20th May 2026	7:00 am	RNS	Holding(s) in Company
16th Apr 2026	12:37 pm	RNS	Holding(s) in Company
31st Dec 2025	8:22 am	RNS	Half-year Financial Report
31st Dec 2025	8:22 am	RNS	Half-year Financial Report
21st Nov 2025	1:38 pm	RNS	Result of AGM
30th Oct 2025	7:30 am	RNS	Restoration - Provexis plc
30th Oct 2025	7:00 am	RNS	Final Results
1st Oct 2025	7:30 am	RNS	Suspension - Provexis PLC
30th Sep 2025	8:40 am	RNS	Delay in publication of annual accounts
7th Jan 2025	1:14 pm	RNS	Grant of Options and Warrants
31st Dec 2024	1:00 pm	RNS	Total Voting Rights
31st Dec 2024	9:59 am	RNS	Half-year Report
18th Dec 2024	7:00 am	RNS	Purchase of Fruitflow® II SD & royalty payment
25th Oct 2024	3:47 pm	RNS	Result of AGM
30th Sep 2024	7:00 am	RNS	Final Results
30th Apr 2024	5:00 pm	RNS	Total Voting Rights
28th Mar 2024	7:00 am	RNS	Issue of Equity - purchase of FruitflowÂ® II SD
29th Dec 2023	12:48 pm	RNS	Half-year Report
26th Oct 2023	1:51 pm	RNS	Result of AGM
29th Sep 2023	7:00 am	RNS	Final Results
30th Aug 2023	7:04 am	RNS	BYHEALTH regulatory filing with Chinese SAMR
3rd Apr 2023	7:00 am	RNS	Capital structure and funding update
24th Jan 2023	11:03 am	RNS	Grant of Share Options
30th Dec 2022	8:53 am	RNS	Half-year Report
27th Oct 2022	1:12 pm	RNS	Result of AGM
14th Oct 2022	7:00 am	RNS	Directorate Change
30th Sep 2022	7:00 am	RNS	Final Results
22nd Jun 2022	7:00 am	RNS	Two new agreements with DSM & patent application
31st May 2022	5:00 pm	RNS	Total Voting Rights
17th May 2022	12:39 pm	RNS	Exercise of Options and Total Voting Rights
31st Dec 2021	7:00 am	RNS	Half-year Report
26th Nov 2021	4:41 pm	RNS	Second Price Monitoring Extn
26th Nov 2021	4:36 pm	RNS	Price Monitoring Extension
4th Nov 2021	1:30 pm	RNS	Result of AGM
4th Nov 2021	11:07 am	RNS	By-Health Fruitflow agreement and support in R&D
1st Oct 2021	6:04 pm	RNS	Grant of Share Options
30th Sep 2021	7:00 am	RNS	Final Results
9th Sep 2021	4:41 pm	RNS	Second Price Monitoring Extn
9th Sep 2021	4:35 pm	RNS	Price Monitoring Extension
24th Aug 2021	4:35 pm	RNS	Price Monitoring Extension
22nd Jul 2021	4:40 pm	RNS	Second Price Monitoring Extn
22nd Jul 2021	4:35 pm	RNS	Price Monitoring Extension
21st Jul 2021	4:41 pm	RNS	Second Price Monitoring Extn
21st Jul 2021	4:36 pm	RNS	Price Monitoring Extension
5th Jul 2021	4:35 pm	RNS	Price Monitoring Extension
1st Jul 2021	4:40 pm	RNS	Second Price Monitoring Extn
1st Jul 2021	4:35 pm	RNS	Price Monitoring Extension
26th Feb 2021	5:00 pm	RNS	Total Voting Rights
19th Feb 2021	7:30 am	RNS	Director / PDMR notification
19th Feb 2021	7:00 am	RNS	Placing of new ordinary shares to raise £50,000

Latest Share Chat

Provexis Regulatory News (PXS)

Share Price Information for Provexis (PXS)

Intraday Provexis Share Chart

Change of Adviser

Please enter at least 2 characters

No results found

Search results

Recently viewed

Trending